Business Scoop » Helius Celebrates Female Leadership In Cannabis Sector scoop.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scoop.co.nz Daily Mail and Mail on Sunday newspapers.
Joanna Perry MNZM has been appointed to the Board of Helius Therapeutics – New Zealand’s largest licenced medicinal cannabis company.
The Chartered Accountant Fellow joins as an Independent Director and will Chair the Board’s Audit Finance Committee.
The appointment of Ms Perry comes as the 100% New Zealand-owned private company prepares to enter both domestic and international markets.
“Joanna’s significant governance experience, combined with her well-known inquisitive probing, will be a real asset. Her nature to challenge and always seek continuous improvement strongly aligns with Helius’ internal cultural value of staying curious,” says Carmen Doran, Chief Executive of Helius Therapeutics.
Wed, 30 Jun 2021 Joanna Perry.
Joanna Perry MNZM has been appointed to the board of New Zealand licenced medicinal cannabis company Helius Therapeutics.
The chartered accountant fellow joins as an independent director and will chair the board’s Audit Finance Committee.
Perry’s appointment comes as the 100% New Zealand-owned private company prepares to enter both domestic and international markets.
“Joanna’s significant governance experience, combined with her well-known inquisitive probing, will be a real asset,” Helius chief executive Carmen Doran said.
Perry holds other senior independent directorships. As with many previous governance roles, she often leads responsibility for audit and risk. She has held many regulatory, advisory, standards and reporting-related roles, and was a long-time member of the former Crown entity, Securities Commission of New Zealand.
Press Release – Helius Therapeutics
Joanna Perry MNZM has been appointed to the Board of Helius Therapeutics – New Zealand’s largest licenced medicinal cannabis company.
New Helius board member, Joanna Perry MNZM.
The Chartered Accountant Fellow joins as an Independent Director and will Chair the Board’s Audit Finance Committee.
The appointment of Ms Perry comes as the 100% New Zealand-owned private company prepares to enter both domestic and international markets.
“Joanna’s significant governance experience, combined with her well-known inquisitive probing, will be a real asset. Her nature to challenge and always seek continuous improvement strongly aligns with Helius’ internal cultural value of staying curious,” says Carmen Doran, Chief Executive of Helius Therapeutics.
We could be due for a redesign of our regulatory architecture bankingday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bankingday.com Daily Mail and Mail on Sunday newspapers.